GO Therapeutics Competitors and Similar CompaniesClear all
GO Therapeutics's competitors and similar companies include Stemline Therapeutics, Peloton Therapeutics, Nykode Therapeutics and LegoChem Biosciences.
 GO Therapeutics GO Therapeutics is a company developing a range of cancer drug candidates that are tumor-specific. |  Stemline Therapeutics Stemline Therapeutics is a clinical stage biopharmaceutical company developing oncology compounds that target cancer stem cells. |  Peloton Therapeutics Peloton Therapeutics is involved in discovering and developing novel drugs for cancer treatments. |  Nykode Therapeutics Nykode Therapeutics (formerly known as Vaccibody) is a biopharmaceutical company dedicated to the discovery and development of immunotherapies. |  LegoChem Biosciences LegoChem Biosciences (레고켐바이오, LCB) is a research-based biotechnology company dedicated to the discovery, development, and commercialization of medicines. | |
Founding Date | Founding Date 2014 | Founding Date 2003 | Founding Date 2011 | Founding Date 2007 | Founding Date 2006 |
Type | Type Private | Type Public | Type Subsidiary | Type Public | Type Public |
Tags | |||||
Locations | Locations Natick, US HQ Cambridge, US | Locations New York, US HQ | Locations Dallas, US HQ San Francisco, US | Locations Oslo, NO HQ | Locations HQ |
Employees | Employees 9 | Employees 100 | Employees 554% increase | Employees 135 | Employees 94 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 621.2 m | Valuation ($) N/A | Valuation ($) 144.4 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) ₩141.6b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $4.9m (FY, 2019) | Cost of goods N/A | Cost of goods $1.3m (FY, 2025) | Cost of goods ₩11.4b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit N/A | Gross profit ($801k) (FY, 2025) | Gross profit ₩130.4b (FY, 2025) |
Net income | Net income N/A | Net income ($76.8m) (FY, 2019) | Net income ($36.1m) (FY, 2018) | Net income ($12.2m) (FY, 2025) | Net income (₩91.5b) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 5m | Total funding raised N/A | Total funding raised $ 92.6m | Total funding raised $ 31.5m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Stemline Therapeutics
HQ
New York, US
Employees
100
Stemline Therapeutics is a clinical stage biopharmaceutical company developing oncology compounds that target cancer stem cells.
View companyPeloton Therapeutics
HQ
Dallas, US
Peloton Therapeutics is involved in discovering and developing novel drugs for cancer treatments.
View companyNykode Therapeutics
HQ
Oslo, NO
Employees
135
Nykode Therapeutics (formerly known as Vaccibody) is a biopharmaceutical company dedicated to the discovery and development of immunotherapies.
View companyLegoChem Biosciences
HQ
Employees
94
LegoChem Biosciences (레고켐바이오, LCB) is a research-based biotechnology company dedicated to the discovery, development, and commercialization of medicines.
View company